Literature DB >> 19552639

Chronic venous insufficiency is associated with elevated level of circulating microparticles.

A Georgescu1, N Alexandru, D Popov, M Amuzescu, E Andrei, C Zamfir, H Maniu, A Badila.   

Abstract

BACKGROUND: Chronic venous insufficiency (CVI) results when the veins in the legs no longer pump blood back to the heart effectively. Microparticles (MPs) are small membrane vesicles released by several circulating and vascular cells upon activation or apoptosis.
OBJECTIVES: The purpose of this study was to assess the subpopulations of circulating endothelial (EMPs) and platelet microparticles (PMPs) in CVI, and to disclose their contribution in mediating dysfunction of human peripheral venules. PATIENTS AND METHODS: Human peripheral venules were explanted during leg surgery on patients with CVI and on control subjects (C); concurrently, blood samples were collected and circulating MPs isolated. The techniques used were: flow cytometry, fluorescence and electron microscopy, myograph technique and western-blotting technique.
RESULTS: The results showed that compared with controls, patients with CVI had: (i) a marked elevation of circulating EMPs and PMPs; (ii) a structural modification of the venous wall consisting of activation of endothelial and smooth muscle cells, an abundance of intermediary filaments and synthesis of hyperplasic-multilayered basal lamina; (iii) a significantly altered reactivity of the venous wall, closely associated with EMPs and PMPs adherence; (iv) altered contractile response to noradrenaline, acetylcholine, 5-hydroxytryptamine and KCl, and an impeded relaxation in response to sodium nitroprusside; and (iv) a substantially increased protein expression of tissue factor (TF) and of P-Selectin both in the venular vascular wall and on the surface of EMPs and PMPs.
CONCLUSIONS: The findings indicate that CVI is accompanied by an enhanced release of EMPs and PMPs that contribute to altered dysfunctional response of the venous wall.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19552639     DOI: 10.1111/j.1538-7836.2009.03525.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  11 in total

1.  Proteomics of microparticles after deep venous thrombosis.

Authors:  Eduardo Ramacciotti; Angela E Hawley; Shirley K Wrobleski; Daniel D Myers; John R Strahler; Philip C Andrews; Kenneth E Guire; Peter K Henke; Thomas W Wakefield
Journal:  Thromb Res       Date:  2010-02-13       Impact factor: 3.944

2.  Low dose aspirin as adjuvant treatment for venous leg ulceration: pragmatic, randomised, double blind, placebo controlled trial (Aspirin4VLU).

Authors:  Andrew Jull; Angela Wadham; Chris Bullen; Varsha Parag; Ngaire Kerse; Jill Waters
Journal:  BMJ       Date:  2017-11-24

3.  Intravenous Administration of Allogenic Cell-Derived Microvesicles of Healthy Origins Defend Against Atherosclerotic Cardiovascular Disease Development by a Direct Action on Endothelial Progenitor Cells.

Authors:  Nicoleta Alexandru; Eugen Andrei; Florentina Safciuc; Emanuel Dragan; Ana Maria Balahura; Elisabeta Badila; Adriana Georgescu
Journal:  Cells       Date:  2020-02-12       Impact factor: 6.600

4.  Hypertension Associated With Hyperlipidemia Induced Different MicroRNA Expression Profiles in Plasma, Platelets, and Platelet-Derived Microvesicles; Effects of Endothelial Progenitor Cell Therapy.

Authors:  Nicoleta Alexandru; Alina Constantin; Miruna Nemecz; Ioana Karla Comariţa; Alexandra Vîlcu; Anastasia Procopciuc; Gabriela Tanko; Adriana Georgescu
Journal:  Front Med (Lausanne)       Date:  2019-12-03

Review 5.  Extracellular vesicles-incorporated microRNA signature as biomarker and diagnosis of prediabetes state and its complications.

Authors:  Nicoleta Alexandru; Anastasia Procopciuc; Alexandra Vîlcu; Ioana Karla Comariţa; Elisabeta Bӑdilӑ; Adriana Georgescu
Journal:  Rev Endocr Metab Disord       Date:  2021-06-18       Impact factor: 6.514

Review 6.  Extracellular Vesicles: Versatile Nanomediators, Potential Biomarkers and Therapeutic Agents in Atherosclerosis and COVID-19-Related Thrombosis.

Authors:  Adriana Georgescu; Maya Simionescu
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

Review 7.  Endothelial Progenitor Cell-Derived Extracellular Vesicles: Potential Therapeutic Application in Tissue Repair and Regeneration.

Authors:  Sonia Terriaca; Elena Fiorelli; Maria Giovanna Scioli; Giulia Fabbri; Gabriele Storti; Valerio Cervelli; Augusto Orlandi
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

8.  Circulating endothelial progenitor cell and platelet microparticle impact on platelet activation in hypertension associated with hypercholesterolemia.

Authors:  Nicoleta Alexandru; Doina Popov; Emanuel Dragan; Eugen Andrei; Adriana Georgescu
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

9.  Plasma concentration of selected biochemical markers of endothelial dysfunction in women with various severity of chronic venous insufficiency (CVI)-A pilot study.

Authors:  Magdalena Budzyń; Maria Iskra; Wojciech Turkiewicz; Zbigniew Krasiński; Bogna Gryszczyńska; Magdalena Paulina Kasprzak
Journal:  PLoS One       Date:  2018-01-29       Impact factor: 3.240

Review 10.  The Multifaceted Role of Extracellular Vesicles in Glioblastoma: microRNA Nanocarriers for Disease Progression and Gene Therapy.

Authors:  Natalia Simionescu; Radu Zonda; Anca Roxana Petrovici; Adriana Georgescu
Journal:  Pharmaceutics       Date:  2021-06-29       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.